CluePoints

📍 Avenue Albert Einstein 2A, Belgium🗓 Founded 2012👥 265 employees💰 Last funded Jul 2024
CluePoints is the premier provider of RBQM and data quality oversight software. We’re leveraging the potential of AI using advanced statistics and ML to determine the quality, accuracy, and integrity of clinical trial data both during and after the study. Aligned with guidance from the FDA, EMA, ICH, and MHRA, CluePoints supports central and on-site monitoring, medical review, and quality risk management to drive a holistic risk-based strategy. Coupled with thought leadership and consulting expertise to aid risk assessment and solution implementation, the result is positive clinical development outcomes, increased operational efficiency, lower costs, and reduced regulatory submission risk as part of the industry paradigm shift to RBQM. To learn more about CluePoints, visit CluePoints.com.
4
Total investors
1
Early stage
1
Mid stage
1
Late stage
2012
Founded
Investor geography2 countries
Belgium
2
United Kingdom
2
Investor activity2013–2024 · investors recorded per year
20131201512020120241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in CluePoints?
CluePoints has 4 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage and 1 late-stage investors.
When did CluePoints last raise funding?
The most recent investment in CluePoints recorded on gritt.io was in July 2024.
When was CluePoints founded?
CluePoints was founded in 2012.
What industry is CluePoints in?
CluePoints operates in Software Development. Find similar Software Development investors on gritt.io.
Where is CluePoints based?
CluePoints is headquartered in Avenue Albert Einstein 2A, Belgium.